Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Shire prepares for Baxalta

Country: Ireland

Shire Plc, the acquisition-oriented specialty pharma company, reported a 6.6% rise in revenue to $6.4 billion for 2015 and a 16.4% decline in operating profit to $1.4 billion using US GAAP. On a non-GAAP basis it reported an 11% rise in both revenue and operating income.

Read more

Lundbeck sees recovery

Country: Denmark

H. Lundbeck A/S, the Danish specialist in brain diseases, said the worst is over after reporting an operating loss of DKK 6.8 billion (€910 million) for 2015, reflecting the cost of a major restructuring programme and a reclassification of certain product rights.

Read more

Zika virus task force

Country: United Kingdom

Read more

EMA nod for myeloma drug

Country: United Kingdom

Read more

Sanofi reports mixed results

Country: France

Read more

Imperial Innovations deepens investment in Aqdot

Country: United Kingdom

Read more

New money for deep brain stimulation

Country: Switzerland

Read more

Index Ventures hives off life science funds

Country: United Kingdom

Read more

Novo Nordisk had a banner year

Country: Denmark

Read more

Series A for French viral therapy company

Country: France

Read more

GSK sees earnings growth in 2016

Country: United Kingdom

Read more

Mission Therapeutics raises £60 million

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Improving gene regulation in cell and gene therapy, by Michael Roberts

CommentarySyntheticBiologyMichaelRobertsJan16.pdf

Highlights of the January 2016 MedNous issue

The January 2016 MedNous features:

Latest Mednous cover
  • Oncology Review
    More new cancer drugs
    reached the market in 2015
    By Bruno Pagliara
  • Synthetic Biology:
    Improving gene regulation
    in cell and gene therapy
    By Michael Roberts
  • Virus-like particles
    A new approach for
    treating peanut allergy?
    Interview with Matthias Kramer and Martin Bachmann
  • Stock Market Review
    European biotechs advance
  • Regenerative Medicine
    Syncona backs new gene therapy company

The latest MedNous journal. Subscribe to download.

Recent Appointments